Blastomycosis (Blastomyces dermatitidis)



Introduction

Blastomycosis is a systemic fungal disease caused by Blastomyces dermatitidis. It is a dimorphic fungus that exists as a mold in the environment and as a yeast in animal tissues. The disease primarily affects the lungs after inhalation of spores and can disseminate to the skin, bones, and other organs. Dogs are the most commonly affected domestic animals, with important zoonotic implications for humans.

Etiology
Causative Agent
  • Blastomyces dermatitidis
Organism Characteristics
  • Dimorphic fungus:
    • Mold form in soil (25°C)
    • Yeast form in host tissues (37°C)
  • Produces thick-walled yeast with broad-based budding
  • Thrives in moist, acidic soil rich in decaying organic matter
Epidemiology
Species Affected
  • Dogs (most commonly affected domestic species)
  • Cats (less frequently affected)
  • Horses (rare cases)
  • Humans (important zoonotic disease)
Geographical Distribution
  • Endemic in North America (especially near waterways and forested areas)
  • Reported in parts of Africa and other temperate regions
Environmental Reservoir
  • Moist soil
  • Decaying vegetation
  • Riverbanks, lakesides, and wooded areas
Transmission
  • Inhalation of airborne conidia (spores)
  • No direct animal-to-animal transmission
Risk Factors
  • Exposure to moist, wooded environments
  • Outdoor hunting or working dogs
  • Disturbance of contaminated soil
  • Immunosuppression
Pathogenesis
Respiratory Infection

Inhaled spores reach the alveoli and convert into yeast forms at body temperature.

Pulmonary Phase
  • Initial infection occurs in lungs
  • Granulomatous inflammation develops
Dissemination
  • Spread via bloodstream and lymphatics
  • Commonly affects skin, bones, eyes, and lymph nodes
Immune Response
  • Chronic granulomatous inflammation
  • Suppurative and pyogranulomatous lesions
Clinical Signs
Respiratory Signs
  • Coughing
  • Dyspnea
  • Exercise intolerance
Systemic Signs
  • Fever
  • Weight loss
  • Lethargy
Skin Lesions (Common in Dogs)
  • Ulcerative or nodular dermatitis
  • Draining tracts
  • Non-healing wounds
Ocular and Skeletal Signs
  • Uveitis and vision loss
  • Lameness due to bone involvement
Summary for Practitioners

Blastomycosis should be suspected in dogs with respiratory disease combined with skin lesions and a history of exposure to wooded or riverine environments.

Postmortem Findings
Gross Lesions
  • Nodular lesions in lungs
  • Enlarged lymph nodes
  • Ulcerative skin lesions
  • Bone lesions in disseminated disease
Microscopic Lesions
  • Large yeast cells with thick walls and broad-based budding
  • Pyogranulomatous inflammation
  • Tissue necrosis and fibrosis
Diagnosis
Clinical Diagnosis

Based on respiratory signs, skin lesions, and environmental exposure history.

Laboratory Diagnosis
  • Cytology (identification of broad-based budding yeast)
  • Histopathology
  • Fungal culture (definitive diagnosis)
  • Serology (supportive but variable sensitivity)
  • PCR (in specialized laboratories)
Differential Diagnosis
  • Histoplasmosis
  • Coccidioidomycosis
  • Tuberculosis
  • Neoplasia (especially lymphoma)
Summary for Practitioners

The presence of broad-based budding yeast in cytology is highly suggestive of blastomycosis.

Treatment
Antifungal Therapy
  • Itraconazole (treatment of choice for most cases)
  • Amphotericin B (severe or disseminated disease)
  • Fluconazole (alternative in some cases, especially CNS involvement)
Supportive Therapy
  • Anti-inflammatory drugs
  • Nutritional support
  • Oxygen therapy in severe respiratory disease
Summary for Practitioners

Prolonged antifungal therapy (weeks to months) is required for successful resolution of infection.

Control and Prevention
Environmental Measures
  • Avoid high-risk endemic areas where possible
  • Minimize disturbance of moist soil and decaying vegetation
Animal Management
  • Restrict access of working dogs to high-risk environments
  • Early detection and treatment of suspected cases
Biosecurity
  • No effective vaccine available
  • Focus on exposure prevention
Summary for Practitioners

Prevention is primarily based on reducing environmental exposure rather than medical prophylaxis.

Zoonotic Importance

Blastomycosis is a zoonotic disease. Humans can become infected through inhalation of spores from contaminated environments, especially in endemic regions. Direct transmission from animals is rare but possible through exposure to infected tissues.

Economic Importance

The disease causes significant veterinary costs due to long treatment duration, mortality in valuable animals (especially working dogs), and public health concerns in endemic areas.

Summary

Blastomycosis is a systemic dimorphic fungal disease caused by Blastomyces dermatitidis. It primarily affects dogs and is characterized by respiratory disease with possible dissemination to skin, bones, and other organs. Diagnosis relies on cytology and culture, while treatment requires prolonged antifungal therapy.